Scalable, reproducible and customizable NGS data analysis workflows on cloud for clinical diagnostics and translational research with automated report generation and interactive visualizations
We strongly believe in bringing power of personalized actionable insights from genomics data to the clinicians for serving their patients effectively.
A total of 23 million adverse drug reactions (ADRs) were reported in the World Health Organization pharmacovigilance database between 2010 to 2019. Immunomodulating drugs used in treating cancer patients are the top category of drug class with the largest reported ADRs. These ADRs are completely preventable with pharmacogenomics testing. Please contact us to provide your patients and clinicians with the most effective and safe treatment options.
An end-to-end solution for predicting and prioritizing personalized T and B cell epitopes/neoepitopes from tumor or disease sample sequencing data